
Slim Mzoughi, PhD
About Me
Dr. Slim Mzoughi is an Assistant Professor of Oncological Sciences and co-founder of the Center for OncoGenomics and Innovative Therapeutics. His research focuses on understanding how cancer cells adapt, evolve, and develop drug resistance, with the goal of uncovering vulnerabilities beyond traditional genetic prediction.
Dr. Mzoughi earned a PhD through the SINGA scholarship at the National University of Singapore, where he pioneered research on PRDM15, an uncharacterized epigenetic regulator, resulting in several high-impact publications. At the Icahn School of Medicine at Mount Sinai, his team investigates the epigenetic mechanisms that enable cancer cell plasticity, uncovering new dependencies that drive therapy resistance and paving the way for transformative treatments.
Recognized as an emerging leader in the field, he was recently selected as a Forbeck Scholar and has received prestigious funding, including an NIH R01 grant, to support his innovative research program.
Language
Position
Research Topics
Cancer, Cancer Genetics, Chromatin, Developmental Biology, Epigenetics, Epigenomics, Gene Expressions, Gene Regulation, Genomics, Regeneration, Stem Cells, Tumorigenesis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]
About Me
Dr. Slim Mzoughi is an Assistant Professor of Oncological Sciences and co-founder of the Center for OncoGenomics and Innovative Therapeutics. His research focuses on understanding how cancer cells adapt, evolve, and develop drug resistance, with the goal of uncovering vulnerabilities beyond traditional genetic prediction.
Dr. Mzoughi earned a PhD through the SINGA scholarship at the National University of Singapore, where he pioneered research on PRDM15, an uncharacterized epigenetic regulator, resulting in several high-impact publications. At the Icahn School of Medicine at Mount Sinai, his team investigates the epigenetic mechanisms that enable cancer cell plasticity, uncovering new dependencies that drive therapy resistance and paving the way for transformative treatments.
Recognized as an emerging leader in the field, he was recently selected as a Forbeck Scholar and has received prestigious funding, including an NIH R01 grant, to support his innovative research program.
Language
Position
Research Topics
Cancer, Cancer Genetics, Chromatin, Developmental Biology, Epigenetics, Epigenomics, Gene Expressions, Gene Regulation, Genomics, Regeneration, Stem Cells, Tumorigenesis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]